In the world of cardiology, the growth of AI is set to be a real game changer. Medical centres have been quick to realise the challenges they face in managing care for patients with cardiac conditions, in particular the time it takes to read and assess the growing number of ECGs being processed.
Cardiologs is a clinical decision support system (CDSS) designed to help physicians detect anomalies in a patient’s heart activity. Though it primarily focuses on detecting atrial fibrillation - a condition which affects around 33 million people globally - Cardiologs is highly scalable, and capable of spotting more than 100 different kinds of cardiac abnormalities.
With clinical studies proving that Cardiolog's deep learning AI greatly outperforms its counterparts, the company is a stand-out in the market. In 2021 it was acquired by Philips, a global leader in health technology, which will enable the larger company to expand its value while affording Cardiologs the resources to continue innovation and development.
Kirsty
Company Specialist at Welcome to the Jungle